BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.010
-0.020 (-1.94%)
At close: Jun 27, 2025, 4:00 PM
0.9998
-0.0100 (-1.01%)
After-hours: Jun 27, 2025, 7:59 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $18.73 million as of June 27, 2025. Its market cap has decreased by -37.99% in one year.
Market Cap
18.73M
Enterprise Value
-4.06M
1-Year Change
-37.99%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $18.73M, a decrease of -63.99%. That is a compound annual growth rate of -19.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 18.70M | -47.32% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |